Pharmacological Management of Hypertrophic Cardiomyopathy

20 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Patients with hypertrophic cardiomyopathy (HCM) can have a multitude of symptoms, such as shortness of breath, chest pain, palpitations, fatigue, and fainting. Improving these symptoms is the main goal of treatment. In this CardioBites video, we explore the recent advances in first-line therapies such as beta blockers, calcium channel blockers, and the new cardiac myosin inhibitors that may invoke a paradigm shift in our treatment of HCM.

Please visit our post-module evaluation survey as well!
Link to survey: https://www.surveymonkey.com/r/8RL5D9K

View More CardioHub Programs: https://hfsa.org/cardiohub
HFSA LinkedIn: / hfsa
HFSA Twitter: / hfsa
HFSA Learning Center: https://learningcenter.hfsa.org/
Join HFSA to enjoy member benefits: https://hfsa.org/membership/membership-benefits-and-categories
Categoria
Cardiology
Commenta per primo questo video.

Prossimo